Pilot project: European Web Survey on Drugs: patterns of use
The EMCDDA is currently developing estimates of the size of the drug market in the EU based on data provided routinely to the EMCDDA by National Focal Points. One key component of such market size estimates, for which there is no routine data collection and only limited data available, is the quantities of substances used by different groups of drug users. Read more >>
For this pilot study, in a first phase, the survey was conducted in different countries across Europe. The countries were: Croatia, the Czech Republic, France, the Netherlands, Switzerland and the United Kingdom. The surveys ran at different times.
For the second round, the following countries will participate: Austria (closed), Belgium (closed), Cyprus, Estonia (closed), Finland (closed), Italy (closed), Latvia (closed), Lithuania (closed), Luxembourg, Poland (closed) and United Kingdom.
Background and context
The EMCDDA is currently developing estimates of the size of the drug market in the EU based on data provided routinely to the EMCDDA by National Focal Points. One key component of such market size estimates, for which there is no routine data collection and only limited data available, is the quantities of substances used by different groups of drug users. The data that is available has tended to come mainly from small scale studies of specific heavy user groups, for example of people entering treatment. On the other hand, General Population Surveys generally do not have sufficiently large samples of drug users to provide robust information on amounts.
For the report Further Insights into the EU drug markets, researchers from Trimbos Institute coordinated an online survey of drug users in seven EU countries, which included the collection of information about amounts used as well as frequency of use and sources of supply. The data collected provided valuable information on the variation in quantities used per occasion by different user groups in different countries. It also demonstrated the potential of this approach for obtaining information from drug users in different countries in a quick and cost-effective manner, while highlighting areas requiring further development to improve the method for the future.
The EMCDDA is therefore undertaking a pilot project to build on the earlier survey experience and develop a system and the capacity within EMCDDA for collecting such data. This would not only be of value to the EMCDDA but would also be a valuable resource for National Focal Points allowing them to obtain valuable information for policy development at the national level quickly and at low cost. If successful, it is anticipated that the range of topics covered would be developed further in the future.
Aims and objectives
The project aims to develop and test a web survey tool or tools to collect information on the amounts of drugs used by different groups of drug users and to draft guidance for adapting and administering it in different countries. The objective is to assist EMCDDA in the development of a tool that can be offered to National Focal Points with a view to increasing the information available on quantities of drugs used in order to enhance market size estimation at both the national and European level and for use in policy development more widely.
For more information/queries, please contact João Matias.
Proposed work programme
The aim is to develop a web survey module and accompanying guidance that can be used by National Focal Points to collect information on topics, such as amounts of drugs used by different groups of drug users, that are not feasible to include in General Population Surveys (GPS) because of the small numbers of drug users, particularly frequent drug users, that such surveys cover. While not being representative of the general population, web surveys carefully conducted may nevertheless provide valuable information about variations in use among different groups of drug use that can be a valuable adjunct to GPS. If a common approach is taken to developing the sampling strategies, the same questions are used along with rigorous translation processes then they may also provide useful cross-national comparisons. Thus if this pilot is successful there is the potential to extend the project to include other countries and other topics adding to the European knowledge base in a quick and cost-effective manner.
Building on the questionnaire used for the Further Insights into the EU drug markets report and the lessons learned from that process a web survey tool or tools will be developed to collect information on quantities of drugs used by users of the following drugs: cannabis, amphetamines, cocaine and ecstasy.
For the second round of the project, a module on ‘New Psychoactive Substances’ (NPS) was added and the original module for amphetamines will be split into two: amphetamine and methamphetamine. These modules have been pre-tested at national level.
Deciding the recruitment strategy to use in each country to ensure coverage of the important user groups for each drug within that country will be important to ensuring the quality of the data obtained. Guidance on doing this will be developed and participant countries will be involved in discussions about the best approaches to share ideas and experience. For the second round, the feasibility of recruiting participants via the ‘darknet’ will be tested as well as the potential to carry out sentiment analysis on the qualitative information produced.
As for the first round, the intention is to do the data cleaning and initial analysis at the EMCDDA to ensure compatibility. Countries will be provided with their data for their own use.
Emerging findings of the first round:
Approach very promising: quick, big user samples and cheap
Good collaborative working
Acceptable to users: positive comments and agree to follow-up
Value of European branding & central web page
Data cleaning takes a lot of time – more attention to routing and range controls needed
Not a panacea: not generalisable to the whole population - complement not replacement for GPS
Current recruitment strategies have mainly reached recreational users
More comprehensive results will be published in the future and links to these resources will be added as they become available.
A first meeting with the participant countries was held alongside the Head of National Focal Points meeting in November 2015, to discuss the practical details of the study and share ideas.
A web-based forum was created as a tool for the participating countries to share ideas, strategies and documents related to the project.
Data collection for the second round will run in different time periods for the different participating countries, starting in October 2017.
Videos are available in the following languages:
Austria: Austrian Public Health Institute (Gesundheit Österreich GmbH) and Checkit! - Viennese Drugs Services (Suchthilfe Wien gGmbH)
Belgium: Scientific Institute of public health -WIV-ISP
Estonia: National Institute for Health Development
Finland: National Institute for Health and Welfare
Latvia: The Centre for Disease Prevention and Control of Latvia (Slimību profilakses un kontroles centrs)
Lithuania: Lithuanian national focal point
Poland: National Bureau for Drug Prevention